Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

101 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Loss of paraspinal muscle mass is a gender-specific consequence of cirrhosis that predicts complications and death.
Engelmann C, Schob S, Nonnenmacher I, Werlich L, Aehling N, Ullrich S, Kaiser T, Krohn S, Herber A, Sucher R, Bartels M, Surov A, Hasenclever D, Kahn T, Seehofer D, Moche M, Berg T. Engelmann C, et al. Among authors: moche m. Aliment Pharmacol Ther. 2018 Dec;48(11-12):1271-1281. doi: 10.1111/apt.15026. Epub 2018 Nov 11. Aliment Pharmacol Ther. 2018. PMID: 30417398
Repeated percutaneous hepatic perfusion with melphalan can maintain long-term response in patients with liver cancers.
Veelken R, Maiwald B, Strocka S, Petersen TO, Moche M, Ebel S, Denecke T, Rehak M, Struck MF, Forstmeyer D, Rademacher S, Seehofer D, Berg T, van Bömmel F. Veelken R, et al. Among authors: moche m. Cardiovasc Intervent Radiol. 2022 Feb;45(2):218-222. doi: 10.1007/s00270-021-02983-2. Epub 2021 Oct 29. Cardiovasc Intervent Radiol. 2022. PMID: 34716470 Free PMC article.
Liver resection for hepatocellular carcinoma in patients without cirrhosis.
Thelen A, Benckert C, Tautenhahn HM, Hau HM, Bartels M, Linnemann J, Bertolini J, Moche M, Wittekind C, Jonas S. Thelen A, et al. Among authors: moche m. Br J Surg. 2013 Jan;100(1):130-7. doi: 10.1002/bjs.8962. Epub 2012 Nov 6. Br J Surg. 2013. PMID: 23132620 Free article.
Early tumor shrinkage and response assessment according to mRECIST predict overall survival in hepatocellular carcinoma patients under sorafenib.
Öcal O, Schinner R, Schütte K, de Toni EN, Loewe C, van Delden O, Vandecaveye V, Gebauer B, Zech CJ, Sengel C, Bargellini I, Gasbarrini A, Sangro B, Pech M, Malfertheiner P, Ricke J, Seidensticker M; SORAMIC study group. Öcal O, et al. Cancer Imaging. 2022 Jan 4;22(1):1. doi: 10.1186/s40644-021-00439-x. Cancer Imaging. 2022. PMID: 34983668 Free PMC article.
101 results